Standard
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. / Muñoz, Nubia; Kjaer, Susanne K; Sigurdsson, Kristján; Iversen, Ole-Erik; Hernandez-Avila, Mauricio; Wheeler, Cosette M; Perez, Gonzalo; Brown, Darron R; Koutsky, Laura A; Tay, Eng Hseon; Garcia, Patricía J; Ault, Kevin A; Garland, Suzanne M; Leodolter, Sepp; Olsson, Sven-Eric; Tang, Grace W K; Ferris, Daron G; Paavonen, Jorma; Steben, Marc; Bosch, F Xavier; Dillner, Joakim; Huh, Warner K; Joura, Elmar A; Kurman, Robert J; Majewski, Slawomir; Myers, Evan R; Villa, Luisa L; Taddeo, Frank J; Roberts, Christine; Tadesse, Amha; Bryan, Janine T; Lupinacci, Lisa C; Giacoletti, Katherine E D; Sings, Heather L; James, Margaret K; Hesley, Teresa M; Barr, Eliav; Haupt, Richard M.
In:
National Cancer Institute. Journal (Online), Vol. 102, No. 5, 03.03.2010, p. 325-39.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Muñoz, N, Kjaer, SK, Sigurdsson, K, Iversen, O-E, Hernandez-Avila, M, Wheeler, CM, Perez, G
, Brown, DR, Koutsky, LA, Tay, EH, Garcia, PJ, Ault, KA, Garland, SM, Leodolter, S, Olsson, S-E, Tang, GWK, Ferris, DG, Paavonen, J, Steben, M, Bosch, FX, Dillner, J, Huh, WK, Joura, EA, Kurman, RJ, Majewski, S, Myers, ER, Villa, LL, Taddeo, FJ, Roberts, C, Tadesse, A, Bryan, JT, Lupinacci, LC, Giacoletti, KED, Sings, HL, James, MK, Hesley, TM, Barr, E & Haupt, RM 2010, '
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women',
National Cancer Institute. Journal (Online), vol. 102, no. 5, pp. 325-39.
https://doi.org/10.1093/jnci/djp534APA
Muñoz, N., Kjaer, S. K., Sigurdsson, K., Iversen, O-E., Hernandez-Avila, M., Wheeler, C. M., Perez, G.
, Brown, D. R., Koutsky, L. A., Tay, E. H., Garcia, P. J., Ault, K. A., Garland, S. M., Leodolter, S., Olsson, S-E., Tang, G. W. K., Ferris, D. G., Paavonen, J., Steben, M., ... Haupt, R. M. (2010).
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
National Cancer Institute. Journal (Online),
102(5), 325-39.
https://doi.org/10.1093/jnci/djp534Vancouver
Muñoz N, Kjaer SK, Sigurdsson K, Iversen O-E, Hernandez-Avila M, Wheeler CM et al.
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
National Cancer Institute. Journal (Online). 2010 Mar 3;102(5):325-39.
https://doi.org/10.1093/jnci/djp534Author
Muñoz, Nubia ; Kjaer, Susanne K ; Sigurdsson, Kristján ; Iversen, Ole-Erik ; Hernandez-Avila, Mauricio ; Wheeler, Cosette M ; Perez, Gonzalo ; Brown, Darron R ; Koutsky, Laura A ; Tay, Eng Hseon ; Garcia, Patricía J ; Ault, Kevin A ; Garland, Suzanne M ; Leodolter, Sepp ; Olsson, Sven-Eric ; Tang, Grace W K ; Ferris, Daron G ; Paavonen, Jorma ; Steben, Marc ; Bosch, F Xavier ; Dillner, Joakim ; Huh, Warner K ; Joura, Elmar A ; Kurman, Robert J ; Majewski, Slawomir ; Myers, Evan R ; Villa, Luisa L ; Taddeo, Frank J ; Roberts, Christine ; Tadesse, Amha ; Bryan, Janine T ; Lupinacci, Lisa C ; Giacoletti, Katherine E D ; Sings, Heather L ; James, Margaret K ; Hesley, Teresa M ; Barr, Eliav ; Haupt, Richard M. / Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. In: National Cancer Institute. Journal (Online). 2010 ; Vol. 102, No. 5. pp. 325-39.
Bibtex
@article{3450e6d1877940838ef383649d59157f,
title = "Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women",
abstract = "The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was investigated in a population that approximates sexually naive women in that they were {"}negative to 14 HPV types{"} and in a mixed population of HPV-exposed and -unexposed women (intention-to-treat group).",
author = "Nubia Mu{\~n}oz and Kjaer, {Susanne K} and Kristj{\'a}n Sigurdsson and Ole-Erik Iversen and Mauricio Hernandez-Avila and Wheeler, {Cosette M} and Gonzalo Perez and Brown, {Darron R} and Koutsky, {Laura A} and Tay, {Eng Hseon} and Garcia, {Patric{\'i}a J} and Ault, {Kevin A} and Garland, {Suzanne M} and Sepp Leodolter and Sven-Eric Olsson and Tang, {Grace W K} and Ferris, {Daron G} and Jorma Paavonen and Marc Steben and Bosch, {F Xavier} and Joakim Dillner and Huh, {Warner K} and Joura, {Elmar A} and Kurman, {Robert J} and Slawomir Majewski and Myers, {Evan R} and Villa, {Luisa L} and Taddeo, {Frank J} and Christine Roberts and Amha Tadesse and Bryan, {Janine T} and Lupinacci, {Lisa C} and Giacoletti, {Katherine E D} and Sings, {Heather L} and James, {Margaret K} and Hesley, {Teresa M} and Eliav Barr and Haupt, {Richard M}",
year = "2010",
month = mar,
day = "3",
doi = "http://dx.doi.org/10.1093/jnci/djp534",
language = "English",
volume = "102",
pages = "325--39",
journal = "National Cancer Institute. Journal (Online)",
issn = "1460-2105",
publisher = "Oxford University Press",
number = "5",
}
RIS
TY - JOUR
T1 - Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women
AU - Muñoz, Nubia
AU - Kjaer, Susanne K
AU - Sigurdsson, Kristján
AU - Iversen, Ole-Erik
AU - Hernandez-Avila, Mauricio
AU - Wheeler, Cosette M
AU - Perez, Gonzalo
AU - Brown, Darron R
AU - Koutsky, Laura A
AU - Tay, Eng Hseon
AU - Garcia, Patricía J
AU - Ault, Kevin A
AU - Garland, Suzanne M
AU - Leodolter, Sepp
AU - Olsson, Sven-Eric
AU - Tang, Grace W K
AU - Ferris, Daron G
AU - Paavonen, Jorma
AU - Steben, Marc
AU - Bosch, F Xavier
AU - Dillner, Joakim
AU - Huh, Warner K
AU - Joura, Elmar A
AU - Kurman, Robert J
AU - Majewski, Slawomir
AU - Myers, Evan R
AU - Villa, Luisa L
AU - Taddeo, Frank J
AU - Roberts, Christine
AU - Tadesse, Amha
AU - Bryan, Janine T
AU - Lupinacci, Lisa C
AU - Giacoletti, Katherine E D
AU - Sings, Heather L
AU - James, Margaret K
AU - Hesley, Teresa M
AU - Barr, Eliav
AU - Haupt, Richard M
PY - 2010/3/3
Y1 - 2010/3/3
N2 - The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was investigated in a population that approximates sexually naive women in that they were "negative to 14 HPV types" and in a mixed population of HPV-exposed and -unexposed women (intention-to-treat group).
AB - The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was investigated in a population that approximates sexually naive women in that they were "negative to 14 HPV types" and in a mixed population of HPV-exposed and -unexposed women (intention-to-treat group).
U2 - http://dx.doi.org/10.1093/jnci/djp534
DO - http://dx.doi.org/10.1093/jnci/djp534
M3 - Journal article
VL - 102
SP - 325
EP - 339
JO - National Cancer Institute. Journal (Online)
JF - National Cancer Institute. Journal (Online)
SN - 1460-2105
IS - 5
ER -
